NO20004313L - Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer - Google Patents
Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemerInfo
- Publication number
- NO20004313L NO20004313L NO20004313A NO20004313A NO20004313L NO 20004313 L NO20004313 L NO 20004313L NO 20004313 A NO20004313 A NO 20004313A NO 20004313 A NO20004313 A NO 20004313A NO 20004313 L NO20004313 L NO 20004313L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- lipoxygenase inhibitors
- formula
- heterocyclic ring
- ring systems
- Prior art date
Links
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 239000011541 reaction mixture Substances 0.000 abstract 2
- 239000011734 sodium Substances 0.000 abstract 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052792 caesium Inorganic materials 0.000 abstract 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- 239000012299 nitrogen atmosphere Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052701 rubidium Inorganic materials 0.000 abstract 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
Abstract
Det er beskrevet et nytt mellomprodukt, tetrahydro-4-[3-(4-fluorfenyl)tio}fenyl- 2H-pyran-4-karboksamid, ifølge formel: F, ONH2 samt anvendelse derav i en fremgangsmåte for fremstilling av 5-lipoksygenase- inhibitorer ifølge formelen: CONH2 som omfatter etablering av en reaksjonsblanding bestående av F.. CONHj -og- en elektronmanglende monocyklisk eller benzo-kondensert bicyklisk N-heterocyklisk gruppe inneholdende to nitrogenatomer ifølge formlene: R" i et aprotisk løsningsmiddel; i nærvær av et karbonat ifølge formel: (M^-COj, hvori M er et alkalimetall, gruppe 1/la element, valgt fra gruppen bestående av litium, Li; natrium, Nå; kalium, K; rubidium, Rb; og cesium, Cs; etterfulgt av oppvarming av nevnte reaksjonsblanding under en nitrogenatmosfære; hvorved det blir produsert ønsket forbindelse ifølge ovenfor angitte formel.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15161599P | 1999-08-31 | 1999-08-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004313D0 NO20004313D0 (no) | 2000-08-30 |
| NO20004313L true NO20004313L (no) | 2001-03-01 |
Family
ID=22539529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004313A NO20004313L (no) | 1999-08-31 | 2000-08-30 | Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6346624B1 (no) |
| EP (1) | EP1081143A1 (no) |
| JP (1) | JP2001106682A (no) |
| KR (1) | KR20010050256A (no) |
| CN (1) | CN1286250A (no) |
| AP (1) | AP2000001910A0 (no) |
| AU (1) | AU5360300A (no) |
| BG (1) | BG104731A (no) |
| BR (1) | BR0003945A (no) |
| CA (1) | CA2317097A1 (no) |
| CZ (1) | CZ20003158A3 (no) |
| EA (1) | EA200000801A1 (no) |
| EE (1) | EE200000512A (no) |
| GT (1) | GT200000142A (no) |
| HR (1) | HRP20000564A2 (no) |
| HU (1) | HUP0003439A3 (no) |
| ID (1) | ID27129A (no) |
| IL (1) | IL138087A0 (no) |
| IS (1) | IS5603A (no) |
| MA (1) | MA26751A1 (no) |
| NO (1) | NO20004313L (no) |
| NZ (1) | NZ506632A (no) |
| OA (1) | OA11452A (no) |
| PA (1) | PA8499701A1 (no) |
| PE (1) | PE20010520A1 (no) |
| PL (1) | PL342281A1 (no) |
| SG (1) | SG87146A1 (no) |
| SK (1) | SK12872000A3 (no) |
| SV (1) | SV2002000159A (no) |
| TN (1) | TNSN00177A1 (no) |
| TR (1) | TR200002529A2 (no) |
| UY (1) | UY26314A1 (no) |
| ZA (1) | ZA200004435B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6669042B1 (en) * | 2002-09-30 | 2003-12-30 | Hewlett-Packard Development Company, L.P. | Integrated positioning and locking device |
| EP1834953A1 (en) * | 2006-03-14 | 2007-09-19 | Ranbaxy Laboratories Limited | Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| US6063928A (en) * | 1994-10-18 | 2000-05-16 | Pfizer Inc | 5-lipoxygenase inhibitors |
| SK281577B6 (sk) | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
| US6239285B1 (en) * | 1998-02-06 | 2001-05-29 | Pfizer Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
-
2000
- 2000-06-29 US US09/607,011 patent/US6346624B1/en not_active Expired - Fee Related
- 2000-08-01 SG SG200004341A patent/SG87146A1/en unknown
- 2000-08-10 PA PA20008499701A patent/PA8499701A1/es unknown
- 2000-08-16 EP EP00307014A patent/EP1081143A1/en not_active Withdrawn
- 2000-08-18 OA OA1200000225A patent/OA11452A/en unknown
- 2000-08-24 IL IL13808700A patent/IL138087A0/xx unknown
- 2000-08-24 AU AU53603/00A patent/AU5360300A/en not_active Abandoned
- 2000-08-25 SK SK1287-2000A patent/SK12872000A3/sk unknown
- 2000-08-25 IS IS5603A patent/IS5603A/is unknown
- 2000-08-28 UY UY26314A patent/UY26314A1/es not_active Application Discontinuation
- 2000-08-28 GT GT200000142A patent/GT200000142A/es unknown
- 2000-08-28 ID IDP20000711A patent/ID27129A/id unknown
- 2000-08-28 ZA ZA200004435A patent/ZA200004435B/xx unknown
- 2000-08-29 PE PE2000000885A patent/PE20010520A1/es not_active Application Discontinuation
- 2000-08-29 JP JP2000259063A patent/JP2001106682A/ja active Pending
- 2000-08-29 CA CA002317097A patent/CA2317097A1/en not_active Abandoned
- 2000-08-29 BG BG104731A patent/BG104731A/xx unknown
- 2000-08-30 SV SV2000000159A patent/SV2002000159A/es unknown
- 2000-08-30 KR KR1020000050608A patent/KR20010050256A/ko not_active Abandoned
- 2000-08-30 CZ CZ20003158A patent/CZ20003158A3/cs unknown
- 2000-08-30 HR HR20000564A patent/HRP20000564A2/hr not_active Application Discontinuation
- 2000-08-30 EA EA200000801A patent/EA200000801A1/ru unknown
- 2000-08-30 TN TNTNSN00177A patent/TNSN00177A1/fr unknown
- 2000-08-30 MA MA26054A patent/MA26751A1/fr unknown
- 2000-08-30 HU HU0003439A patent/HUP0003439A3/hu unknown
- 2000-08-30 NO NO20004313A patent/NO20004313L/no not_active Application Discontinuation
- 2000-08-30 CN CN00126408A patent/CN1286250A/zh active Pending
- 2000-08-30 NZ NZ506632A patent/NZ506632A/en unknown
- 2000-08-31 AP APAP/P/2000/001910A patent/AP2000001910A0/en unknown
- 2000-08-31 PL PL00342281A patent/PL342281A1/xx not_active Application Discontinuation
- 2000-08-31 BR BR0003945-4A patent/BR0003945A/pt not_active IP Right Cessation
- 2000-08-31 TR TR2000/02529A patent/TR200002529A2/xx unknown
- 2000-08-31 EE EEP200000512A patent/EE200000512A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU589155B2 (en) | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido) azabicycloalkanes | |
| ES433835A1 (es) | Un procedimiento de obtencion de un compuesto de piridini- loxi (tio) fenilurea. | |
| MX154758A (es) | Procedimiento para preparacion de derivados de succinimida | |
| TR200000993T2 (tr) | Endotelin antagonistleri. | |
| IE33124B1 (en) | New heterocyclic carboxylic acids their derivatives and use | |
| DK527984A (da) | 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika | |
| NO20004313L (no) | Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer | |
| ES2001703A6 (es) | Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos. | |
| JPS5392767A (en) | Preparation of 2-phthalimidomethylindole derivatives | |
| GB9907458D0 (en) | Processes for preparing pesticidal intermediates | |
| DK118386A (da) | Beta-lactam-antibiotika, deres fremstilling og anvendelse som laegemidler | |
| JPS51128982A (en) | New corbostyril derivatives and pharmaceutical compositions containing thereof | |
| ES449068A1 (es) | Procedimiento para preparar derivados de isoxazol. | |
| HRP960369B1 (en) | Process for the preparation of epoxide | |
| ES472295A1 (es) | Procedimiento de obtencion de nuevas acilureas con actividadfarmacologica | |
| ES476273A1 (es) | Un procedimiento para preparar nuevos analogos de cefalospo-rina | |
| ES510823A0 (es) | Procedimiento de preparacion de un nuevo derivado de acido benzamido-alquil-hidroxamico. | |
| ES8707213A1 (es) | Procedimiento para preparar dihidro-1,4-tiazinas aroil-sustituidas | |
| JPS53121787A (en) | Preparation of oxazolinoazetidinylpentenoic acid derivatives | |
| JPS5392766A (en) | Preparation of 2-aminomethylindole derivatives | |
| GR75072B (no) | ||
| JPS5422362A (en) | Preparation of alpha-thienylpropionic acid | |
| JPS53141110A (en) | Ceillng structure of industrial ceramic furnace | |
| JPS532476A (en) | Synthesis of 4-substituted-dithio-2-azetidinone derivatives | |
| GB1065966A (en) | Dibenzocyclo-octenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |